December 27, 2012 - (Pluristem) - "Pluristem Therapeutics, Inc., a leading developer of placenta-based cell therapies, announced today it has initiated the final validation steps for it new "state-of-the-art" manufacturing facility prior to taking possession of the facility." Read Full Article
